Journals / Anadolu Kardiyoloji Dergisi / 2005 / Cilt: 5 - Sayı: 1

Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery

Topikal uygulanan aprotinin ve traneksamik asitin açık kalp cerrahisi sonrası kan kaybına etkisi

Pages
36–40
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Topical application of aprotininand tranexamic acid reduced postoperative bleeding, but this was not statistically significan The differences were insignificant for effectiveness between aprotinin and tranexamic acid and for transfusion requirements.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We sought to investigate the effects of topical applications of aprotinin and tranexamic acid in preventing postoperative ble eding during open heart surgery.
📊
Key Findings & Data:Grou| 1 ( n = 10) received 1000000 KIU aprotinin, Group 2 (n= 10) received 1 grtranexamic acid and Group 3 (n = 10) received placebo before do sure of the sternotomy.
💡
Conclusion & Impact:Conclusion: Topical application of aprotininand tranexamic acid reduced postoperative bleeding, but this was not statistically significan The differences were insignificant for effectiveness between aprotinin and tranexamic acid and for transfusion requirements.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: We sought to investigate the effects of topical applications of aprotinin and tranexamic acid in preventing postoperative ble eding during open heart surgery. Methods: Thirty patients undergoing open heart surgery with cardiopulmonary bypass were randomized to three different groups. Grou| 1 ( n = 10) received 1000000 KIU aprotinin, Group 2 (n= 10) received 1 grtranexamic acid and Group 3 (n = 10) received placebo before do sure of the sternotomy. During the first three hours and 24 hours total postoperative blood loss and amount of transfused blood product were recorded. Results: In Group 1, postoperative bleeding rates were 122 ml during first 3 hours, 302 ml during 24 hours and 384 ml total. In Group 2, pos toperative bleeding rates were 108 ml during first 3 hours, 305 ml during 24 hours and 393 ml total. In control group, bleeding rates were 162,347 and 502 ml, respectively. Needs for transfusion were 4.7 U in the aprotinin group, 5.4 U in the tranexamic acid group and 6.0 U in the control group. Conclusion: Topical application of aprotininand tranexamic acid reduced postoperative bleeding, but this was not statistically significan The differences were insignificant for effectiveness between aprotinin and tranexamic acid and for transfusion requirements.

Özet

Amaç: Açık kalp cerrahisi esnasındaki postoperatif kanamanın engellenmesinde topikal uygulanan aprotinin ve traneksamik asitin etkisin araştırmayı amaçladık. Yöntemler: Kardiyopulmoner baypas ile açık kalp cerrahisi yapılan 30 hasta 3 farklı gruba randomize edildi. Sternum kapatılmadan önce 1 gruba (n=10) 1000000 KIU aprotinin, 2. gruba (n=10) 2 gr. traneksamik asit ve 3. gruba (n=10) plasebo verildi. Ameliyat sonrası ilk üç saatte ki ve 24. saatteki toplam kan kaybı ve verilen kan ürünleri miktarı kaydedildi. Bulgular: Aprotinin alan grupta, postoperatif kan kaybı ilk üç saatte 122 ml, 24. saatte 302 ml ve toplam olarak 384 ml idi. Traneksamik asi verilen grupta postoperatif kanama ilk üç saatte 108 ml, 24, saatte 305 ml ve toplam olarak 393 ml idi. Kontrol grubunda ise sırasıyla 162,34; ve 502 ml idi. Transfüzyon ihtiyacı aprotinin grubunda 4.7 Ü, traneksamik asit grubunda 5.4 Ü ve kontrol grubunda 6 Ü idi. Sonuç: Aprotinin ve traneksamik asitin lokal uygulanması postoperatif kanamayı bir miktar azaltmaktadır ancak bu istatistiksel olarak anlamlı değildir. Aprotinin ve traneksamik asitin etkinliği arasında ise bir farklılık gözlenmemiştir. Ayrıca transfüzyon ihtiyacında da bir farklılık yoktu.

🔖

Cite This Article

YASIM, A., AŞIK, R., ATAHAN, E. (2022). Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery. Anadolu Kardiyoloji Dergisi, Cilt: 5 - Sayı: 1, 36–40. https://ajindex.com/articles/437436

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Tatar H, Çiçek S, Demirkılıç U, et al. Topical use of aprotinin in open heart operation. Ann Thorac Surg 1993; 55: 659-61. 2. De Bonis M, Cavaliere F, Alessandrini F, et al. Topical use of tranexamic acid in coronary artery bypass operations: a double - blind, prospective, randomized, placebo–controlled study. J Thorac Cardiovasc Surg 2000;119:575-80. 3. Rocha E, Hidalgo F, Llorens R, Melero JM, Arroyo JL, Paramo JA. Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation 1994; 90: 921-7. 4. Casati V, Guzzon D, Oppizzi M, et al. Tranexamic acid compared with high – dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogenic transfusions. J Thorac Cardiovasc Surg 2000; 120: 520-7. 5. Huang H, Ding W, Su Z, Zhang W. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg 1993; 106: 11-8. 6. Casati V, Bellotti F, Gerli C, et al. Tranexamic acid administration after cardiac surgery. Anesthesiology 2001; 94: 8-14. 7. Jamieson WRE, Dryden PJ, O’Connor JP, Sadeghi H, Ansley DM, Merrick PM. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.Circulation 1997;96 (suppl):II96- 101. 8. Mongan PD, Brown RS, Thwaites BK. Tranexamic acid and aprotinin reduce postoperative bleeding and transfusion during primary coronary revascularization. Anesth Analg 1998; 87: 258-65. 9. Katoh J, Tsuchiya K, Sato W, Nakajima M, Iida Y. Additional postbypass administration of tranexamic acid reduces blood loss after cardiac operations. J Thorac Cardiovasc Surg 1997; 113: 802-4. 10. Casati V, Sandrelli L, Speziali G, Calori G, Grasso MA, Spagnola S. Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: A prospective, randomized, double–blind, placebo–controlled study. J Thorac Cardiovasc Surg 2002; 123: 1084–91. 11. Bidstrup BP, Harrison J, Royston D, Taylor KM, Treasure T. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 1993; 55: 971-6. 12. O’Regan DJ, Giannopoulos N, Mediratta N, et al. Topical aprotinin in cardiac operations. Ann Thorac Surg 1994; 58: 778-81. 13. Lemmer JH, Stanford W, Bonney SL, et al. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. J Thorac Cardiovasc Surg 1994; 107: